← Back to Screener
Adagio Medical Holdings, Inc Common Stock (ADGM)
Price$0.77
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-23.94%
Price vs S&P 500 (4W)-34.68%
VGM Score24.69
Market Capitalization$16.08M
All Metrics
Book Value / Share (Quarterly)$0.26
P/TBV (Annual)4.05x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.72
Price vs S&P 500 (YTD)-41.32%
EPS (TTM)$-1.39
10-Day Avg Trading Volume0.17M
EPS Excl Extra (TTM)$-1.39
EPS (Annual)$-1.51
ROI (Annual)-75.01%
Gross Margin (Annual)-451.16%
Cash / Share (Quarterly)$0.58
ROA (Last FY)-57.99%
EBITD / Share (TTM)$-1.02
Cash Flow / Share (Annual)$-0.87
P/B Ratio2.81x
P/B Ratio (Quarterly)4.46x
Net Income / Employee (Annual)$-611,800
Net Interest Coverage (TTM)-6.40x
ROA (TTM)-64.98%
EPS Incl Extra (Annual)$-1.51
Current Ratio (Annual)2.44x
Quick Ratio (Quarterly)1.54x
3-Month Avg Trading Volume0.11M
52-Week Price Return-39.16%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.24
P/S Ratio (Annual)26.71x
Asset Turnover (Annual)0.01x
52-Week High$2.58
EPS Excl Extra (Annual)$-1.51
26-Week Price Return-8.01%
Quick Ratio (Annual)2.12x
13-Week Price Return-29.71%
Total Debt / Equity (Annual)1.70x
Current Ratio (Quarterly)1.85x
Enterprise Value$26.04M
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-12465.28%
Cash / Share (Annual)$0.77
3-Month Return Std Dev112.41%
Net Income / Employee (TTM)$-594,300
ROE (Last FY)-202.26%
Net Interest Coverage (Annual)-1.73x
EPS Basic Excl Extra (Annual)$-1.51
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)4.00x
EPS Incl Extra (TTM)$-1.39
ROI (TTM)-48.77%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.24
Price vs S&P 500 (52W)-67.37%
Year-to-Date Return-30.38%
5-Day Price Return-13.91%
EPS Normalized (Annual)$-1.51
ROA (5Y Avg)-150.53%
Net Profit Margin (Annual)-12465.28%
Month-to-Date Return-19.58%
EBITD / Share (Annual)$-1.26
Operating Margin (Annual)-13980.07%
LT Debt / Equity (Annual)1.70x
LT Debt / Equity (Quarterly)4.00x
EPS Basic Excl Extra (TTM)$-1.39
P/TBV (Quarterly)4.05x
P/B Ratio (Annual)1.78x
Inventory Turnover (TTM)0.22x
Book Value / Share (Annual)$0.56
Price vs S&P 500 (13W)-39.45%
Beta-0.21x
Revenue / Share (TTM)$0.00
ROE (TTM)-159.53%
52-Week Low$0.70
mGradeD
vgmGradeD
Show chart for
Earnings Surprise History
Q1 26-0.31est. -0.30
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.14
4.14
4.14
4.13
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ADGMAdagio Medical Holdings, Inc Common Stock | — | — | D | $0.77 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
Adagio Medical Holdings develops cryoablation catheter systems for treating cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia. The company's proprietary technology creates contiguous, transmural lesions designed to improve treatment durability and patient outcomes. Adagio addresses both paroxysmal and persistent arrhythmias, targeting a substantial portion of the cardiac electrophysiology market.